Tenders/91/PN/2026 - Successive supply of radiopharmaceutical: lutetium Lu-177 oxodotreotate (Lutathera) for UCK
Awarded🇵🇱PolandSupplies

91/PN/2026 - Successive supply of radiopharmaceutical: lutetium Lu-177 oxodotreotate (Lutathera) for UCK

Auto-translated from Polish
Original title: 91/PN/2026- Sukcesywna dostawa radiofarmaceutyku: oksodotreotydu lutetu Lu-177 (Lutathera) dla UCK
Uniwersyteckie Centrum Kliniczne
Published: Jul 7, 2026
Updated: Jul 20, 2026
Source: TED - Tenders Electronic Daily (EU)

This tender has been awarded

Awarded to Urtica Sp. z o.o.; Pharmalink sp. z o.o — €16,320,000

Browse open Energy & Power tenders in Poland

About This Opportunity

This is a supplies contract in the energy and power sector. Located in Poland, Europe, this opportunity is open to firms and consortiums.

Published through TED - Tenders Electronic Daily (EU), a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the energy and power sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.

Description

Auto-translated from Polish

1. The subject of the order is the successive supply of the radiopharmaceutical: lutetium Lu-177 oxodotreotate (Lutathera) for UCK in the assortment, estimated quantity, and boundary requirements specified in Annex No. 3 to the SWZ. 2. The Contractor shall deliver the ordered assortment referred to in para. 1 at its own expense to the Department of Nuclear Medicine of UCK, ul. Dębinki 7. The delivery date of the radiopharmaceutical is one working day before its planned administration. 3. The contracting authority does not allow the submission of partial offers. The contracting authority has not divided the order into parts because such a division is impractical in this procedure and would cause significant difficulties and excessive costs in the execution of the order. Additionally, Art. 91 of the Public Procurement Law (PZP) does not impose an absolute obligation to divide the order into parts, but rather grants the contracting authority the right to divide the order, therefore, no claim of illegality of such action can be formulated due to the lack of a norm imposing the obligation to divide. 4. The contracting authority does not consent to changes in Annex No. 3 to the SWZ – assortment and price form, under penalty of rejection.

Data provenance

This notice is sourced from TED - Tenders Electronic Daily (EU) and was originally published on July 7, 2026. Last refreshed 121 days ago. Original language: Polish. BidsFactory mirrors official procurement notices and links back to the source for full legal text.

About Uniwersyteckie Centrum Kliniczne

Uniwersyteckie Centrum Kliniczne has issued 540 procurement notices on BidsFactory, including 22 currently open and 133 awarded contracts. Activity concentrates in Health & Medical, General Supplies & Services, and Information & Communication Technology. All notices are published for Poland. Notices are distributed via TED - Tenders Electronic Daily (EU) and Poland e-Zamówienia. Most recent publication: November 18, 2026.

Uniwersyteckie Centrum Kliniczne: buyer profile, tenders and awards

Frequently asked questions about this tender

What type of contract is this?

This is a Supplies contract in the Energy & Power sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.

How much was the contract awarded for?

Urtica Sp. z o.o.; Pharmalink sp. z o.o was awarded the contract for €16,320,000. The figure reflects the value disclosed by the contracting authority in the award notice.

Where will the contract be performed?

The contract is for delivery in Poland. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.

How can I submit a bid?

Visit TED - Tenders Electronic Daily (EU) to access the full notice, required documents, and submission instructions provided by the contracting authority.

Is this tender still open?

No — the contract has already been awarded to Urtica Sp. z o.o.; Pharmalink sp. z o.o. The award notice is archived on BidsFactory for transparency and market intelligence.

Who is the contracting authority?

This notice was issued by Uniwersyteckie Centrum Kliniczne in Poland. The authority is responsible for evaluating bids, awarding the contract, and managing performance.

Find tenders like this automatically

Premium shows the full details of every tender like this one and alerts you instantly when a new one is published.

See plans

Sectors & Categories

Key Details

Contract Type
Supplies
Eligibility
Firms / Consortiums
Language
Polish

Source

ted
TED - Tenders Electronic Daily (EU)
Public Procurement

Contracting Authority

Uniwersyteckie Centrum Kliniczne
🇵🇱Poland

Contact